Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Details Textual)

v3.3.1.900
Related Party Transactions (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Feb. 22, 2016
Feb. 16, 2016
Jan. 22, 2016
Jun. 09, 2015
Feb. 11, 2015
Jul. 10, 2014
Jul. 10, 2014
Dec. 09, 2013
Jun. 30, 2014
Mar. 24, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Related Party Transactions (Textual)                          
Underwritten offering common stock, Shares                 1,670,000   5,626,119    
Stock issued during period value under subscription agreements                     $ 37,637,959 $ 15,435,305 $ 2,883,257
Gross proceeds from public offering                 $ 12,500,000   15,100,000    
Net proceeds from public offering                     14,700,000    
Sale of stock, Description                   The Company will pay MLV in cash, upon the sale of common stock pursuant to the Sales Agreement, an amount equal to 3.0% of the gross proceeds from the sale of common stock. On April 28, 2014, the Company issued 500 shares and received net proceeds of $6,000 under the Sales Agreement with MLV.      
Subsequent Event [Member]                          
Related Party Transactions (Textual)                          
Underwritten offering common stock, Shares 500 10,750 500                    
Stock issued during period value under subscription agreements   $ 19,350                      
Placement agent [Member]                          
Related Party Transactions (Textual)                          
Description of receivables of placement agent for services               The agreement entered in on December 9, 2013 included a cash fee equal to 10% of the gross proceeds raised, a non-accountable expense reimbursement equal to 2% of the gross proceeds raised and warrants to purchase shares of the Company's Common Stock.          
Description of warrants receivables by placement               Warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued or issuable.          
Monthly fee for financial advisory services               $ 25,000          
Repayment of amount paid to placement agent                     $ 25,000 25,000  
Underwritten offering common stock, Shares                         69,289
Cash fee             $ 455,108         $ 397,303 $ 399,103
Warrants to purchase of common stock                       68,976 69,289
Exercise price of warrants                     $ 9    
Warrants term                     5 years    
Subscription Agreements [Member]                          
Related Party Transactions (Textual)                          
Amount paid to placement agent       $ 400,000                  
Underwritten offering common stock, Shares       1,923,078                  
Stock issued during period value under subscription agreements       $ 5,000,000                  
Share price       $ 2.60                  
IPO [Member]                          
Related Party Transactions (Textual)                          
Amount paid to placement agent         $ 1,400,000                
Underwritten offering common stock, Shares         4,444,444 1,827,123              
Gross proceeds from public offering         $ 20,000,000 $ 13,700,000              
Net proceeds from public offering         $ 18,500,000 $ 12,600,000     $ 11,500,000        
Exercise price of warrants         $ 6.50                
MSKCC [Member]                          
Related Party Transactions (Textual)                          
Maintenance fees                     $ 200,000 $ 300,000 $ 100,000
Royalty description                     Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.    
Number of shares common stock                     5,700,000    
Sale of stock, Description                     Thereafter MSKCC shall be permitted to sell its shares subject to a weekly volume limitation of 150,000 shares (which limit may be increased to up to 250,000 shares per week to the extent any prior weekly allotments are not fully used) and applicable law so long as MSKCC maintains at least 25% of its current shareholding in Actinium through December 31, 2016.    
MSKCC [Member] | Clinical Trial Agreement [Member]                          
Related Party Transactions (Textual)                          
Maintenance fees                     $ 0 $ 200,000